Egypt Edition 
UAE Edition 
Saudi Edition 
MENA <> India Corridor 
Logistics (MENA) 
Climate (MENA) 
Share
Read Full Issue 
The new age of aging is upon us. We’ve all heard the stories: someone who smokes their whole life makes it to 100, while another who follows all the rules of health doesn't get nearly as far. As more research comes in, we’re starting to realize that how long we live isn’t all about luck, or even what’s written in our DNA. Tech is stepping in to help us live longer, healthier lives, and it’s giving us the tools to better understand the science of aging, NYT reports.
(Tap or click the headline above to read this story with all of the links to external sources.)
What really makes us live longer? Science shows that your genes play a big part in how long you’ll live, especially when you’re getting into those older years. But that’s not the whole picture, in fact, lifestyle and environment impact 75% of your lifespan — at least until you’re pushing 100 — after that, genetics seem to take the lead. FOXO3 is a gene tied to better cellular health, and certain variations of APOE can lower your risk of Alzheimer’s.
But AI is lending a helping hand: AI is analyzing massive amounts of data to figure out how genetics, lifestyle, and environment all work together to affect longevity. Companies like Calico Life Sciences and Insilico Medicine are using machine learning to explore the genes of long livers, looking for clues on how we can slow down the aging process. Apps like ZOE and Viome are using AI to personalize your diet and health plan based on your genes and gut microbiome.
Or you get your insight from wearables: If tracking your steps isn’t good enough, gadgets like Oura Ring and Whoop Strap are giving us insights into our health in real time, from how well we sleep to how stressed we are. These devices measure things like heart rate variability and sleep cycles — key indicators of your biological age. When combined with blood tests from companies like InsideTracker, it's like having a personalized life plan in your pocket. On the biotech side, companies like Altos Labs and Unity Biotechnology are working on treatments that could rejuvenate cells and target age-related diseases.
